Similar articles for PMID: 9806504

Year	Number of Results
1967	1
1984	2
1985	1
1986	1
1987	2
1988	4
1989	2
1990	3
1991	5
1992	7
1993	7
1994	11
1995	12
1996	16
1997	18
1998	16
1999	11
2000	8
2001	8
2002	12
2003	8
2004	6
2005	8
2006	6
2007	2
2008	6
2009	9
2010	6
2011	5
2012	3
2013	4
2014	3
2015	2
2016	2
2017	4
2018	2
2019	6
2020	5
2021	4
2022	1
2024	0

1

A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.

Lee JS, Komaki R, Fossella FV, Glisson BS, Hong WK, Cox JD. Lee JS, et al. Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):479-86. doi: 10.1016/s0360-3016(98)00247-8. Int J Radiat Oncol Biol Phys. 1998. PMID: 9806504

2

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.

Lee JS, Scott C, Komaki R, Fossella FV, Dundas GS, McDonald S, Byhardt RW, Curran WJ Jr. Lee JS, et al. J Clin Oncol. 1996 Apr;14(4):1055-64. doi: 10.1200/JCO.1996.14.4.1055. J Clin Oncol. 1996. PMID: 8648357 Clinical Trial.

3

A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.

Park J, Ahn YC, Kim H, Lee SH, Park SH, Lee KE, Lim DH, Park J, Kim K, Jung CW, Im YH, Kang WK, Lee MH, Park K. Park J, et al. Lung Cancer. 2003 Nov;42(2):227-35. doi: 10.1016/s0169-5002(03)00282-4. Lung Cancer. 2003. PMID: 14568691 Clinical Trial.

4

A pilot study of protracted low dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III nonsmall cell lung cancer.

Blanke C, DeVore R, Shyr Y, Epstein B, Murray M, Hande K, Stewart S, Johnson D. Blanke C, et al. Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):111-6. doi: 10.1016/s0360-3016(96)00478-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9054884 Clinical Trial.

5

Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial.

Pöttgen C, Eberhardt W, Bildat S, Stüben G, Stamatis G, Hillejan L, Sohrab S, Teschler H, Seeber S, Sack H, Stuschke M. Pöttgen C, et al. Ann Oncol. 2002 Mar;13(3):403-11. doi: 10.1093/annonc/mdf050. Ann Oncol. 2002. PMID: 11996471 Free article. Clinical Trial.

6

A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.

Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M. Segawa Y, et al. Br J Cancer. 2000 Jan;82(1):104-11. doi: 10.1054/bjoc.1999.0885. Br J Cancer. 2000. PMID: 10638975 Free PMC article. Clinical Trial.

7

Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.

Mirimanoff RO, Moro D, Bolla M, Michel G, Brambilla C, Mermillod B, Miralbell R, Alberto P. Mirimanoff RO, et al. Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):487-94. doi: 10.1016/s0360-3016(98)00246-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9806505 Clinical Trial.

8

Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot study.

Lau DH, Ryu JK, Gandara DR, Rosenthal SA. Lau DH, et al. Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):157-61. doi: 10.1016/s0360-3016(97)00249-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9212018

9

Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.

Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M. Reboul F, et al. Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):343-50. doi: 10.1016/0360-3016(96)00087-9. Int J Radiat Oncol Biol Phys. 1996. PMID: 8635942 Clinical Trial.

10

Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.

Langer CJ, Curran WJ Jr, Keller SM, Catalano R, Fowler W, Blankstein K, Litwin S, Bagchi P, Nash S, Comis R. Langer CJ, et al. Int J Radiat Oncol Biol Phys. 1993 Jun 15;26(3):469-78. doi: 10.1016/0360-3016(93)90965-x. Int J Radiat Oncol Biol Phys. 1993. PMID: 8390421 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

226 results

Results by year